Testicular non-seminomatous germ cell tumor
MONDO:0006447A testicular germ cell tumor characterized by the absence of a seminomatous component. It includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed forms.
Also known as: non-dysgerminomatous germ cell tumor of testis, non-dysgerminomatous germ cell tumour of testis, non-seminomatous germ cell tumor of testis, non-seminomatous germ cell tumour of testis, testicular germ cell tumor non-seminomatous, testicular germ cell tumour non-seminomatous, testicular non seminomatous germ cell tumor, testicular non seminomatous germ cell tumour
1445 clinical trials for this condition and its sub-types, 7 tagged with Testicular non-seminomatous germ cell tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Testicular non-seminomatous germ cell tumor
-
Testicular non-seminomatous germ cell cancer 3 trials · 4 incl. sub-types
3 sub-types
- Testicular embryonal carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Choriocarcinoma of testis 1 trial Sub-types →
- Testicular yolk sac tumor 1 trial Sub-types →
-
Testicular trophoblastic tumor 0 trials · 1 incl. sub-types
1 sub-type
- Choriocarcinoma of testis 1 trial Sub-types →
Most studied deeper sub-types
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Choice or fixed? study tests how to get better data from young cancer patients
Knowledge-focused OngoingThis study enrolls 400 adolescents and young adults (ages 18-39) recently diagnosed with various cancers. Participants are randomly assigned to either choose which health-related questions they answer or receive a fixed set of questions. The goal is to see if giving patients a ch…
Early phase 1 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC